Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Epredia™ Lab Vision™ Melanoma Marker, Pan Ab-1, Mouse Monoclonal Antibody

Ensure accurate, reproducible results in immunohistochemistry experiments with the Epredia™ Melanoma Marker, Pan Ab-1, Mouse Monoclonal Antibody.

Supplier:  Epredia™ MS939R1

 View more versions of this product

Catalog No. MS939R1


Description

Description

Melanoma associated antigens recognized by autologous cytotoxic T cells include MART-1, MAGE-1, MAGE-3, tyrosinase, gp100, gp75, BAGE-1, and GAGE-1.

Host Species: Mouse

Clone: HMB45 (gp100), M2-7C10 (MART-1) and M2-9E3 (MART-1)

Isotype: IgG1/κ + IgG2b/κ + IgG2b/κ

Species Reactivity: Human and Horse. Others not known.

Immunogen: Extract of pigmented melanoma metastases from lymph nodes (HMB45); Recombinant hMART-1 protein (M2-7C10 and M2-9E3)

Molecular Weight: 100kDa (gp100) and 18kDa (MART-1)

Positive Control: Melanoma

Cellular Localization: Cytoplasmic

Recommended for:

  • Immunohistochemistry (Formalin/paraffin)

Note:

USA: RUO; Int'l: RUO

Specifications

Specifications

Melanoma Marker, Pan Ab-1
Monoclonal
Unconjugated
Extract of pigmented melanoma metastases from lymph nodes (HMB45); Recombinant hMART-1 protein (M2-7C10 and M2-9E3)
RUO
Primary
Prediluted
Immunohistochemistry (Paraffin)
HMB45 (gp100, M2-7C10) MART-1 and M2-9E3 (MART-1)
Mouse
1 mL
Cancer and Tumor Biology
Equine
IgG2a κ
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.